Year: 1399
COI: JR_RBMB-9-4_002
Language: EnglishView: 107
This Paper With 6 Page And PDF Format Ready To Download
با استفاده از پرداخت اینترنتی بسیار سریع و ساده می توانید اصل این Paper را که دارای 6 صفحه است به صورت فایل PDF در اختیار داشته باشید.
آدرس ایمیل خود را در کادر زیر وارد نمایید:
Authors
Abstract:
Background: Autoimmunity causes the loss of normal immune homeostasis and involves the presence of autoantibodies and inflammation. Thromboangiitis obliterans or Buergerchr('39')s disease (BD) refers to a type of vascular obstructive syndrome, with tobacco exposure accounting for disease formation and progression. However, the current understanding of autoimmunity is unclear in the context of BD, and the scientific findings are not enough to support autoimmune mechanisms. This study was aimed at investigating autoimmunity factors in patients with BD.
Methods: Clinical and experimental examinations were performed on 80 patients with BD. The diagnostic work-up for autoimmunity was composed of IgM rheumatoid factor (RF), anti-nuclear antibodies (ANA), The erythrocyte sedimentation rate (ESR), anti-cyclic citrullinated peptide (CCP) antibodies, Antiphospholipid antibodies (APA), Anti-cardiolipin antibodies (ACLA), anti-double-stranded DNA (ds-DNA), and extractable nuclear antigen (ENA) profile. Immunomarkers were detected using the quantitative enzyme-linked immunosorbent assay (ELISA).
Results: Raynaudchr('39')s phenomenon (84.93%), cold sensitivity (76.25%), and claudication (73.75%) were the most common symptoms in the BD patients. Also, 64.29% represented with high ANA levels and positive RF, while 42.11% were found with increased ANA and ESR levels. The ANA/RF positive BD patients had ESR> 15 mm/hr and a high prevalence of cold sensitivity, claudication, and Raynaudchr('39')s phenomenon (p> 0.05).
Conclusions: There is a possibility of a non-specific autoimmune disposition among BD patients. RF and ANA could be considered for predicting disease progression.
Keywords:
Paper COI Code
This Paper COI Code is JR_RBMB-9-4_002. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:https://civilica.com/doc/1177946/
How to Cite to This Paper:
If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:Shapouri-Moghaddam, Abbas and Tavakkol Afshari, Seyed Jalil and Rahimi, Hamid reza and Saeed Modaghegh, Mohammad-Hadi and Mahmoudi, Mahmoud and Ehteshamfar, Seyed Morteza,1399,Para-Clinical and Immunological Evaluation in Buerger's Disease as a Suspected Autoimmune Disease: Case Series,https://civilica.com/doc/1177946
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :- Klein-Weigel P, Volz T, Gutsche-Petrak B, Boehnlein J, Bohlen A. ...
- Narváez J, García-Gómez C, Álvarez L, Santo P, Aparicio M, ...
- Rivera-Chavarría IJ, Brenes-Gutiérrez JD. Thromboangiitis obliterans (Buerger's disease). Ann Med ...
- Jiménez-Ruiz C, Dale L, Mochales JA, Buendía LV, de Granda ...
- Igari K, Inoue Y, Iwai T. The epidemiologic and clinical ...
- Higashi Y, Azuma N, Takeishi Y, Minamino T, Kihara Y, ...
- De JH, Florez A, Fernandez JL, Acin F. Treatment of ...
- Decousus H, Quéré I, Presles E, Becker F, Barrellier M-T, ...
- Del Conde I, Peña C. Buerger disease (thromboangiitis obliterans). Tech ...
- Vijayakumar A, Tiwari R, Kumar Prabhuswamy V. Thromboangiitis obliterans (Buerger's ...
- Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya J-M. Autoimmune diseases ...
- Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke ...
- Smolen JS, Youngchaiyud U, Weidinger P, Kojer M, Endler AT, ...
- Hassoun Z, Lacrosse M, De Ronde T. Intestinal involvement in ...
- Sasaki S, Sakuma M, Kunihara T, Yasuda K. Distribution of ...
- Asouri M, Alinejad Rokni H, Sahraian MA, Fattahi S, Motamed ...
- Kopan R, Ilagan MXG. The canonical Notch signaling pathway: unfolding ...
- Shapouri-Moghaddam A, Mohammadi M, Rahimi HR, Esmaeili H, Mahmoudi M, ...
- Dargon PT, Landry GJ. Buerger's disease. Ann Vasc Surg. 2012;26(6):871-80. ...
- Malik S, Bruner GR, Williams-Weese C, Feo L, Scofield RH, ...
- Ehteshamfar SM, Afshari JT, Modaghegh MS, Mahmoudi M, Kazemzadeh GH, ...
- Fritzler MJ. The antinuclear antibody test: last or lasting gasp?. ...
- Syed RH, Gilliam BE, Moore TL. Rheumatoid factors and anticyclic ...
- Moore TL, Dalrymple AM. Laboratory Studies in Autoimmune Diseases. Mo ...
- Harrison M. Erythrocyte sedimentation rate and C-reactive protein. Aust Prescr. ...
Research Info Management
اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.
Scientometrics
The specifications of the publisher center of this Paper are as follows:
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.
Share this page
More information about COI
COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.
The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.